The life sciences practice at Hogan Lovells International LLP has expertise spanning pharmaceuticals, medical devices, and healthcare regulatory issues, advising leading pharmaceutical clients on contentious and non-contentious matters. Fabien Roy acts as head of the practice, with particular knowledge of pharma, medical devices, and in vitro diagnostic devices. Cláudia Mendes Pinto is key to the team, frequently working on EU and global projects, focusing on advanced therapy medicinal products. Helene Boland is also noted.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- Adverum Biotechnologies
- Balt USA, LLC
- Celgene Corporation
- Dexcom, Inc.
- Establishment Labs
- Synapse Biomedical, Inc.
Highlight-Mandate
- Advising Adverum, a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, on setting up a GDPR-compliant framework for their upcoming clinical trials in the EU and UK and on future clinical activities in the EU/UK.
- Advising Celgene on an ongoing basis with supply chain, manufacturing, and clinical trials regulatory aspects throughout Europe.
- Advising clients on the transition of their devices from the Medical Devices Directive to the Medical Devices Regulation.
Anwält*innen
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Cláudia Mendes Pinto
Praxisleitung
Fabien Roy
Weitere Kernanwält*innen
Claudia Mendes Pinto; Helene Boland